Triptorelin versus cetrorelix in intracytoplasmic sperm injection cycles in women with a single ovary

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 112, Issue 2, 2004, Pages 185-188

  Nikolettos, N ^a   Asimakopoulos, B ^a   Diedrich, K ^b   Al Hasani, S ^b  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Cetrorelix; GnRH analogues; Single ovary; Triptorelin

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; PROGESTERONE; RECOMBINANT FOLLITROPIN; TRIPTORELIN;

ADULT; ARTICLE; ASPIRATION; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION; HORMONE DETERMINATION; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; OOCYTE; OVARY; OVARY FOLLICLE; OVULATION INDUCTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

EID: 1642545575     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2003.06.004     Document Type: Article

References (22)

1. Alper M.M., Seibel M.M., Oskowitz S.P., Smith B.D., Ransil B.J., Taymor M.L. Comparison of follicular response in patients with one or two ovaries in a program of in vitro fertilization. Fertil. Steril. 44:1985;652-655.
2. Boutteville C., Muasher S.J., Acosta A.A., Jones H.W. Jr., Rosenwaks Z. Results of in vitro fertilization attempts in patients with one or two ovaries. Fertil. Steril. 47:1987;821-827.
3. Diamond M.P., Colston Wentz A., Herbert C.M., Pittaway D.E., Maxson W.S., Daniell J.F. One ovary or two: differences in ovulation induction. Fertil. Steril. 41:1984;524-529.
4. Dodds W.G., Chin N., Awadalla S.G., Miller F., Friedman C., Kim M. In vitro fertilization and embryo transfer in patients with one ovary. Fertil. Steril. 48:1987;249-253.
5. Dodson M.G., Young R.L., Poindexter A.N., Gibbons W.E., Rossavik I.K., Findley W.E. Comparison of in vitro fertilization results in women with one or two ovaries. J. Reprod. Med. 32:1987;359-362.
6. Khalifa E., Toner J.P., Muasher S.J., Acosta A.A. Significance of basal follicle - stimulating hormone levels in women with one ovary in a program of in vitro fertilization. Fertil. Steril. 57:1992;835-839.
7. Lass A., Paul M., Margara R., Winston R.M.L. Women with one ovary have decreased response to GnRHa/HMG ovulation induction protocol in IVF but the same pregnancy rate as women with two ovaries. Hum. Reprod. 12:1997;298-300.
8. Levitas E., Furman B., Shoham-Vardi I., Lunenfeld E., Potashnik G. Treatment outcome in women with a single ovary versus patients with two ovaries undergoing in vitro fertilization and embryo transfer (IVF/ET). Eur. J. Obstet. Gyn. Reprod. Biol. 88:2000;197-200.
9. Nargund G., Bromhan D. Comparison of endocrinological and clinical profiles and outcome of IVF cycles in patients with one ovary and two ovaries. J. Assist. Reprod. Genet. 12:1995;458-460.
10. Penzias A.S., Gutmann J.N., Shamma F.N., LaMorte A.I., DeCherney A.H. Ovulation induction with GnRH agonist and human menopausal gonadotropins: response in patients with one versus two ovaries. Int. J. Fertil. Menopausal. Stud. 38:1993;270-273.
11. Asimakopoulos B., Nikolettos N., Al-Hasani S., Diedrich K. An evaluation of the multiple dose protocol of cetrorelix in single ovary women. In Vivo. 27:2003;89-92.
12. Al-Hasani S, Asimakopoulos B, Nikolettos N, Diedrich K. Comparison of the response to ovarian stimulation between women with one ovary and those with two ovaries, in a program of ICSI/ET. Acta Obst Scand 2003;82:845-9.
13. Albano C., Felberbaum R.E., Smitz J.et al. Ovarian stimulation with HMG: results of a prospective randomised phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. Hum. Reprod. 15:2000;526-531.
14. Felberbaum R.E., Albano C., Ludwig M., Riethmüller-Winzen H., Grigat M., Devroey P.et al. Controlled ovarian stimulation for assisted reproduction with hMG and concomitant midcycle administration of the LHRH-antagonist Cetrorelix (Cetrotide) according to the multiple dose protocol - results of a prospective non-controlled phase III study. Hum. Reprod. 15:2000;1015-1020.
15. Ludwig M, Felberbaum RE, Diedrich K. Interactions of GnRH analogues and gonadotrophins. In: Adashi EY, Baird DT, Crosignani (Eds.), Gonadotrophins and fertility, vol. 1. Christengraf, Rom; 1999. p. 125-143.
16. Ludwig M., Katalinic A., Diedrich K. Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis. Arch. Gynecol. Obstet. 265:2001;175-182.
17. Diedrich K., Felberbaum R. New approaches to ovarian stimulation. Hum. Reprod. 13:1998;1s-13s.
18. Hernandez E.R. Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonists. Hum. Reprod. 15:2000;1211-1216.
19. Al-Hasani S., Küpker W., Baschat A.A., Sturm R., Bauer O., Diedrich C.et al. Mini-swim up: a new technique of sperm preparation for intra-cytoplasmic sperm injection. J. Assist. Reprod. Genet. 12:1995;428-433.
20. Al-Hasani S., Ludwig M., Karabulut O., Al-Dimassi F., Bauer O., Sturm R.et al. Results of intracytoplasmic sperm injection (ICSI) using microprocessor controlled TransferMan Eppendorf Manipulator system. J. Middle East Fertil. Soc. 4:1999;41-44.
21. Ludwig M., Felberbaum R.E., Devroy P., Albano C., Riethmüller- Winzen H., Schüler A.et al. Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist cetrorelix in controlled ovarian stimulation for assisted reproduction. Arch. Gynecol. Obstet. 264:2000;29-32.
22. Nikolettos N., Al-Hasani S., Felberbaum R., Demirel L.C., Kupker W., Montzka P.et al. Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders. Eur. J. Obstet. Gynecol. Reprod. Biol. 97:2001;202-207.